Search research articles
Contact Us
Filters
Showing results (131-140 of 190) with videos related to
Page
of 19
Sort By:
Cancers
|
December 1, 2017
Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival
Vincent Ho, Liping Chung, Amandeep Singh, et al.
International Journal of Molecular Sciences
|
January 23, 2024
p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients
Li Ching Ooi, Vincent Ho, Jing Zhou Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2004
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
Corey Cutler, Haesook T Kim, Ephraim Hochberg, et al.
Transplantation and Cellular Therapy
|
September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
Kuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 7, 2010
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia
Collin C Barker, Manza-A Agovi, Brent Logan, et al.
Blood
|
May 10, 2003
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation
Martha Wadleigh, Paul G Richardson, David Zahrieh, et al.
Journal of the American Academy of Dermatology
|
October 8, 2011
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials
Kenneth B Gordon, Kim A Papp, Richard G Langley, et al.
Blood
|
October 2, 2004
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age
Edwin P Alyea, Haesook T Kim, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 23, 2005
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens
Corey Cutler, Shuli Li, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 27, 2010
Prediction of veno-occlusive disease using biomarkers of endothelial injury
Corey Cutler, Haesook T Kim, Shaké Ayanian, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 190) with videos related to
Sort By:
Page
of 19
Cancers
|
December 1, 2017
Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival
Vincent Ho, Liping Chung, Amandeep Singh, et al.
International Journal of Molecular Sciences
|
January 23, 2024
p21 as a Predictor and Prognostic Indicator of Clinical Outcome in Rectal Cancer Patients
Li Ching Ooi, Vincent Ho, Jing Zhou Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 28, 2004
Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation
Corey Cutler, Haesook T Kim, Ephraim Hochberg, et al.
Transplantation and Cellular Therapy
|
September 4, 2021
Ibrutinib in Steroid-Refractory Chronic Graft-versus-Host Disease, a Single-Center Experience
Kuo-Kai Chin, Haesook T Kim, Eno-Abasi Inyang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 7, 2010
Childhood obesity and outcomes after bone marrow transplantation for patients with severe aplastic anemia
Collin C Barker, Manza-A Agovi, Brent Logan, et al.
Blood
|
May 10, 2003
Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation
Martha Wadleigh, Paul G Richardson, David Zahrieh, et al.
Journal of the American Academy of Dermatology
|
October 8, 2011
Long-term safety experience of ustekinumab in patients with moderate to severe psoriasis (Part II of II): results from analyses of infections and malignancy from pooled phase II and III clinical trials
Kenneth B Gordon, Kim A Papp, Richard G Langley, et al.
Blood
|
October 2, 2004
Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older than 50 years of age
Edwin P Alyea, Haesook T Kim, Vincent Ho, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 23, 2005
Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens
Corey Cutler, Shuli Li, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 27, 2010
Prediction of veno-occlusive disease using biomarkers of endothelial injury
Corey Cutler, Haesook T Kim, Shaké Ayanian, et al.
Page
of 19